Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

In a solid pharmaceutical preparation containing water-soluble salts of levothyroxine and/or liothyronine as active ingredients, the water activity of said pharmaceutical preparation is adjusted to values of below 0.4 and, preferably, 0.1 to 0.3, measured at room temperature.

Saved in:
Bibliographic Details
Main Authors Burghart, Walter, Burghart, Kurt, Raneburger, Johannes
Format Patent
LanguageEnglish
Published 23.10.2012
Online AccessGet full text

Cover

More Information
Summary:In a solid pharmaceutical preparation containing water-soluble salts of levothyroxine and/or liothyronine as active ingredients, the water activity of said pharmaceutical preparation is adjusted to values of below 0.4 and, preferably, 0.1 to 0.3, measured at room temperature.